Document Detail

Penicillamine treatment in rheumatoid arthritis. A retrospective study.
MedLine Citation:
PMID:  7368979     Owner:  NLM     Status:  MEDLINE    
Out of 64 patients with rheumatoid arthritis (RA), 42 were treated with D-penicillamine (D-Pa) for more than 6 months and 22 for less than 6 months. The latter patients were excluded from the evaluation of the effect. The former patients were treated with doses of 600-1 250 mg daily for 6-41 months (mean 16.8). The clinical effect was retrospectively assessed as favourable in 24 patients, 12 did not respond and the effect could not be assessed in 6. The clinical assessment was supported by significant reductions of ESR and orosomucoid. Adverse reactions, although rarely serious, led to withdrawal of the drug in 25 (39%) of the 64 patients. It is concluded that D-Pa is a valuable drug in the treatment of severe RA.
O Börjesson; L P Knutsson; B Svensson
Related Documents :
25128969 - Third-generation minimally invasive correction of hallux valgus: technique and early ou...
23792189 - Patient education with or without manual therapy compared to a control group in patient...
23983149 - Repeat post-op voiding trials: an inconvenient correlate with success.
21325859 - Actual outcome in infants with congenital diaphragmatic hernia: the role of a standardi...
11123029 - Therapy of rheumatoid arthritis: new developments and trends.
25076959 - Measuring quality improvement in acute ischemic stroke care: interrupted time series an...
15085969 - Treatment of xanthelasma palpebrarum with argon laser photocoagulation. argon laser and...
25296729 - Dentoskeletal effects of the bite-jumping appliance and the twin-block appliance in the...
2368879 - Selective or total shunts for variceal bleeding.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta medica Scandinavica     Volume:  207     ISSN:  0001-6101     ISO Abbreviation:  Acta Med Scand     Publication Date:  1980  
Date Detail:
Created Date:  1980-06-16     Completed Date:  1980-06-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370330     Medline TA:  Acta Med Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  93-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthritis, Rheumatoid / drug therapy*
Blood Sedimentation
Middle Aged
Orosomucoid / analysis
Penicillamine / administration & dosage,  adverse effects,  therapeutic use*
Retrospective Studies
Time Factors
Reg. No./Substance:
0/Orosomucoid; 52-67-5/Penicillamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Familial occurrence of the haemolytic uraemic syndrome.
Next Document:  Marked decrease in serum HDL cholesterol level during acute myocardial infarction.